Samsung Bioepis Backed By EMA For First Lucentis Biosimilar

Byooviz Ranibizumab Biosimilar Recommended By EMA’s CHMP

 
• By Dean Rudge
  
Eye
Byooviz will be sold in Europe by Biogen • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation